SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+9.33%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$499M
AUM Growth
+$499M
(+15%)
Cap. Flow
+$31.7M
Cap. Flow
% of AUM
6.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
3
Reduced
–
Closed
1
Top Buys
| 1 |
Biogen
BIIB
|
$13.9M |
| 2 |
Innoviva
INVA
|
$12.1M |
| 3 |
SHPG
Shire pic
SHPG
|
$7.6M |
Top Sells
| 1 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$1.86M |
Sector Composition
| 1 | Healthcare | 85.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$19.4B
| $134M | 26.87% | 461,858 +48,000 | +12% | +$13.9M |
|
|
MDCO
2
DELISTED
Medicines Co
MDCO
| $70.5M | 14.14% | 1,922,000 | – | – |
|
3
Ironwood Pharmaceuticals
IRWD
$214M
| $64.4M | 12.91% | 3,367,100 | – | – |
|
|
4
Innoviva
INVA
$1.29B
| $62.6M | 12.55% | 4,535,000 +874,295 | +24% | +$12.1M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $57.4M | 11.5% | 344,000 | – | – |
|
|
ICPT
6
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $53.3M | 10.69% | 635,300 | – | – |
|
|
SHPG
7
DELISTED
Shire pic
SHPG
| $52.2M | 10.46% | 309,000 +45,000 | +17% | +$7.6M |
|
|
NVLN
8
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $3.77M | 0.76% | 1,025,000 | – | – |
|
|
SEEL
9
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $564K | 0.11% | 1,447,906 | – | – |
|
10
AbbVie
ABBV
$372B
| $92K | 0.02% | 1,000 | – | – |
|
|
ACHN
11
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| – | – | -500,000 | Closed | -$1.86M |
|